STI Expert Hour Webinar: Shared Decision Making in Sexual Health

Tuesday, February 25, 2025
11:30AM-12:45PM (PST)
1.25 CME units at no cost

Recording currently unavailable. Please note: No CME available for viewing the webinar recording.

Presenter
Patty Cason, MS, FNP-BC
President, Envision Sexual and Reproductive Health

Course Description
A plethora of national guidelines recommend shared decision making as a person-centered way to engage with patients who are making decisions about their health. The goal is for patients to benefit from the provider’s contribution of scientific information while being acknowledged as the experts on themselves. This session will provide a specific, detailed approach to this and language suggestions to operationalize shared decision-making conversations.

Learning Objectives

  • Define shared decision making
  • Describe three contributions a provider makes during a shared decision-making conversation
  • List four ways to acknowledge a patient

STI Intensive

January 30, 2025

Please join us for a morning half-day STI Intensive offered in-person and virtually at no cost at the University of California, San Francisco at the ZSFG campus. There will also be an in-person (only) afternoon wet-mount at the UCSF Parnassus campus available to a limited number of the morning-training participants at no cost. This event will cover topics including STI epidemiology, syphilis, mycoplasma genitalium, HPV, and biomedical STI prevention. Speakers will include faculty from CAPTC (UCSF), the San Francisco Department of Public Health, and the California Department of Public Health.

½ Day Didactic: Morning – Early Afternoon

  • Hybrid event being offered in-person at UCSF Pride Hall & Virtually by Zoom
  • Onsite breakfast and refreshments provided
  • CME will be offered at no cost
  • Topics will cover STI trends (national and California); biomedical STI prevention; syphilis cases; updates in STI management, with a focus on syphilis, mycoplasma genitalium and HPV.
  • Recording currently unavailable.

Wet Mount: Mid Afternoon-Evening

Previous microscopy skills are required to take this course. Registration prioritized for STI Intensive didactic attendees. Space limited to 12 max capacity.

  • In-person only training being offered at UCSF Parnassus Heights
  • 3-hour laboratory course
  • CME will be offered at no cost
  • Topics will cover CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis. Microscope footage of findings on VWM including trichomonads, yeast and clue cells associated with BV. Experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). Participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.

STI Expert Hour Webinar: Mycoplasma Genitalium – What’s New?

January 18, 2023, 11:30 AM-12:45 PM (PST)

Presented by Dr. Lindley Barbee

This webinar will focus on an update of the clinical and epidemiologic aspects of Mycoplasma genitalium.

Learning Objectives:

  • Describe clinical syndromes associated with Mycoplasma genitalium
  • Recognize trends in M. genitalium antimicrobial resistance
  • Manage difficult treatment issues M. genitalium

May 11, 2022

Over the last year, the Family PACT Program has added several new benefits. These include three new contraceptive methods, a diagnostic test for Mycoplasma genitalium, and modifications in STI treatments based on the 2021 CDC STI Treatment Guidelines. In this webinar, a description of the new benefits will be provided and the Family PACT policies that relate to their utilization will be discussed. There will be ample time to ask questions regarding these and other Family PACT benefits.

Learning Objectives:

  • Describe and explain the three new contraceptive methods and explain how to discuss the advantages and disadvantages of each with Family PACT clients
  • List three circumstances when the use of the diagnostic test for Mycoplasma genitalium is clinically indicated
  • Describe four modifications in STI treatments based on the 2021 CDC STI Treatment Guidelines

Speakers:

  • Michael Policar, MD, MPH
    Professor Emeritus, UCSF
    Senior Medical Advisor, CAPTC and California OFP
    Clinical Fellow, NFPRHA

Resources:

STI Clinical Update Webinar: San Francisco Department of Public Health, San Francisco City Clinic

November 4, 2021

The San Francisco Department of Public Health continues to see concerning rises in sexually transmitted infections (STIs).

This half-day, virtual event provides important updates in the field of sexual health to help providers strengthen the delivery of STI prevention and care. Hear from local experts on STI epidemiology in San Francisco, important recommendations to prevent congenital syphilis, updates from the 2021 CDC STI Treatment Guidelines, and a lively case panel.

Learning Objectives

  1. Summarize current STI trends in San Francisco
  2. Identify and screen those most at risk for syphilis in San Francisco
  3. Describe updated treatment recommendations for chlamydia, gonorrhea, Mycoplasma genitalium, NGU, and trichomonas

2021 Implementing the CDC STI Treatment Guidelines: A Conversation for Family PACT Providers

The long-awaited 2021 CDC Sexually Transmitted Infections Treatment Guidelines were published in MMWR on July 22, 2021. This webinar will focus on significant changes from the 2015 CDC STD Treatment Guidelines, including updated guidelines for the screening, diagnosis and treatment of gonorrhea, chlamydia, syphilis, pelvic inflammatory disease, genital herpes, Mycoplasma genitalium, and vaginal trichomoniasis. To assist health care providers in obtaining a sexual history, the updated “Five P’s” approach will be reviewed. In addition, current Family PACT benefits for each type of sexually transmitted infection discussed in the program will be explained.

Learning Objectives:

  • List 3 examples of sexual history questions for each the “Five P’s” of sexual history taking
  • Explain why the treatment guidelines for both chlamydia and gonorrhea genital tract infections were updated in the 2021 Guidelines
  • List the indications for obtaining chlamydia and gonorrhea samples from the anus and the oropharynx
  • Describe the consequences of Mycoplasma genitalium genital infection in males and females
  • List 2 updates in the 2021 Guidelines regarding vaginal trichomoniasis

Presenters:

Resources: